Keyphrases
Nerve Growth Factor
100%
Autoimmune
100%
Immunoglobulin
100%
Hypoalgesia
100%
Growth Factor Deprivation
100%
Anti-nerve Growth Factor
100%
Antagonism
57%
Intraepidermal Nerve Fiber Density
57%
Tanezumab
57%
Calcitonin Gene-related Peptide
42%
Substance P
42%
Isolectin B4
42%
Nociception
28%
Hot Plate Test
28%
Nav1.8
28%
Glutaminase 1 (GLS1)
14%
Mechanism of Action
14%
Protein Expression
14%
Osteoarthritis
14%
Clinical Trials
14%
Hot Plate
14%
Tail-flick Test
14%
Dorsal Root Ganglion Neurons
14%
Cytochrome c (Cyt c)
14%
Adverse Effects
14%
Chronic Pain Treatment
14%
Acute Pain
14%
Physical Activity
14%
Self-harm
14%
Immunization
14%
Voltage-gated Sodium Channel
14%
Titer
14%
Behavioral Abnormalities
14%
Joint Damage
14%
Non-inflamed
14%
Humanized
14%
Thermal Latency
14%
Nocifensive Behavior
14%
Mechanical Threshold
14%
Delayed Response
14%
Pain Sensitivity
14%
Inflammatory Pain Model
14%
Nerve Growth Factor Inhibitors
14%
Medicine and Dentistry
Immunoglobulin
100%
Nerve Growth Factor
100%
Hypoalgesia
100%
Nerve Fiber
44%
Tanezumab
44%
Nociception
33%
Calcitonin Gene Related Peptide
33%
Isolectin B4
33%
Hot Plate Test
22%
Nav1.8
22%
Epileptic Absence
11%
Adverse Event
11%
Clinical Trial
11%
Protein Expression
11%
Osteoarthritis
11%
Substance P
11%
Pain
11%
Automutilation
11%
Chronic Pain
11%
Physical Activity
11%
Tail
11%
Nerve Growth Factor Antibody
11%
Dorsal Root Ganglion
11%
Inflammatory Pain
11%
Glutaminase
11%
Voltage Gated Sodium Channel
11%
Cytochrome C
11%
Pharmacology, Toxicology and Pharmaceutical Science
Immunoglobulin
100%
Nerve Growth Factor
100%
Hypoalgesia
100%
Tanezumab
44%
Substance P
33%
Calcitonin Gene Related Peptide
33%
Isolectin B4
33%
Hot Plate Test
22%
Epileptic Absence
11%
Adverse Event
11%
Glutaminase
11%
Clinical Trial
11%
Cytochrome C
11%
Chronic Pain
11%
Automutilation
11%
Inflammatory Pain
11%
Voltage Gated Sodium Channel
11%
Nerve Growth Factor Antibody
11%
Osteoarthritis
11%
Pain
11%
Neuroscience
Nerve Growth Factor
100%
Intravenous Immunoglobulin
100%
Nerve Fiber
44%
Tanezumab
44%
Nociception
33%
Calcitonin
33%
Substance P
33%
Isolectin B4
33%
Hot Plate Test
22%
Glutaminase
11%
Behavior (Neuroscience)
11%
Epileptic Absence
11%
Dorsal Root Ganglion
11%
Adverse Effect
11%
Cytochrome C
11%
Protein Expression
11%
Automutilation
11%
Voltage Gated Sodium Channel
11%
Nerve Growth Factor Antibody
11%